SCHEMBL78622

SCHEMBL78622

CCOC(=O)C1=C(c2cccc(-c3ccccc3)c2)CCN(C(=O)OCc2ccccc2)C1CO[Si](C)(C)C(C)(C)C

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.38
NPC1 O15118 1/20 0.38
ALDH1A1 P00352 1/20 0.38
MAPT P10636 1/20 0.38
RAB9A P51151 1/20 0.38
CHRM5 P08912 3/20 0.37
CHRM1 P11229 3/20 0.37
CHRM2 P08172 2/20 0.37
CHRM4 P08173 2/20 0.37
CHRM3 P20309 2/20 0.37
PDK1 Q15118 1/20 0.37
PDK2 Q15119 1/20 0.37
PDK3 Q15120 1/20 0.37
PDK4 Q16654 1/20 0.37
POLB P06746 1/20 0.35
PARP1 P09874 1/20 0.35
ELANE P08246 1/20 0.34
TMEM97 Q5BJF2 1/20 0.34
SIGMAR1 Q99720 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL64061 0.92 CHRM2 (0.38) CHRM5CHRM1CHRM2CHRM4CHRM3
SCHEMBL66854 0.90 CHRM2 (0.38) SMN1; SMN2CHRM5CHRM1CHRM2CHRM4
SCHEMBL64034 0.90 CHRM5 (0.38) SMN1; SMN2NPC1ALDH1A1MAPTRAB9A
SCHEMBL91298 0.86 CHRM5 (0.37) SMN1; SMN2NPC1ALDH1A1MAPTRAB9A
SCHEMBL78781 0.83 KDM4E (0.36) SMN1; SMN2CHRM5CHRM1CHRM2CHRM4
SCHEMBL78412 0.81 PPARG (0.39) SMN1; SMN2NPC1ALDH1A1MAPTRAB9A
SCHEMBL65231 0.81 CHRM5 (0.39) SMN1; SMN2NPC1ALDH1A1MAPTRAB9A
SCHEMBL78185 0.80 PDK1 (0.40) NPC1ALDH1A1MAPTRAB9APDK1
SCHEMBL65084 0.79 REN (0.37)
SCHEMBL78635 0.77 PDK1 (0.35) SMN1; SMN2NPC1ALDH1A1RAB9ACHRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8129538-B1 Renin inhibitors TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-03-06 US disclosed